Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftrazidime plus amikacin for empiric treatment of febrile neutropenic patients
JP Flaherty, D Waitley, B Edlin, D George… - The American journal of …, 1989 - Elsevier
In a multicenter, randomized clinical trial, the efficacy of ciprofloxacin plus azlocillin was
compared with that of a standard regiment of cerftazidime plus amikacin for the initial empiric
treatment of fever in neutropenic cancer patients. In addition, the efficacy of early conversin
from intravenous therapy to orally administered ciprofloxacin was compared with that of
continued ceftrazidime plus amikacin. Seventy-one oncology patients with 79 episodes of
fever and neutropenia were randomly assigned to receive initial empiric antibiotic therapy …
compared with that of a standard regiment of cerftazidime plus amikacin for the initial empiric
treatment of fever in neutropenic cancer patients. In addition, the efficacy of early conversin
from intravenous therapy to orally administered ciprofloxacin was compared with that of
continued ceftrazidime plus amikacin. Seventy-one oncology patients with 79 episodes of
fever and neutropenia were randomly assigned to receive initial empiric antibiotic therapy …
以上显示的是最相近的搜索结果。 查看全部搜索结果